Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × CT-P10 × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 11 Burkitt Lymphoma 8 Lymphoma, Mantle-Cell 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 4 Lymphoma, B-Cell, Marginal Zone 3 Waldenstrom Macroglobulinemia 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia, Biphenotypic, Acute 2 Myelodysplastic Syndromes 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Hodgkin Disease 1 Hematopoietic and Lymphoid System Neoplasm 1 Classic Follicular Lymphoma 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Blast Crisis 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡